Quantcast

NW Bio granted cell production patent (access required)

Posted: 2:45 pm Mon, March 18, 2013
By Daily Record Staff

Northwest Biotherapeutics Inc., of Bethesda, a biotechnology company developing personalized immune therapies for solid tumor cancers, announced that it has been issued a U.S. patent covering novel processes for manufacturing human dendritic cells.

Comments

Comments are closed.

Copyright © 2012, Maryland Daily Record 11 E. Saratoga Street, Baltimore, MD, 21202 · Tel: 443-524-8100